NCT00487591View on ClinicalTrials.gov

An Evaluation of Simvastatin Plus Omacor Compared to Simvastatin Plus Placebo in Subjects With Mixed Dyslipidemia

CompletedOBSERVATIONAL
Enrollment

40

Participants

Timeline

Start Date

November 30, 2006

Primary Completion Date

August 31, 2007

Study Completion Date

August 31, 2007

Conditions
Mixed Dyslipidemia
Interventions
DRUG

Omacor (omega-3-acid ethyl esters)plus simvastatin

Omacor(omega-3-acid ethyl esters) - 4/g day (4 one gram capsules) simvastatin - 20 mg/day (1 tablet/20 mg)

DRUG

simvastatin plus placebo

simvastatin 20mg/day (1 tablet 20 mg)plus 4 capsules matching placebo

All Listed Sponsors
collaborator

Reliant Pharmaceuticals

INDUSTRY

lead

Provident Clinical Research

OTHER

NCT00487591 - An Evaluation of Simvastatin Plus Omacor Compared to Simvastatin Plus Placebo in Subjects With Mixed Dyslipidemia | Biotech Hunter | Biotech Hunter